Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study

Show other versions (1)

Bibliografske podrobnosti
Main Authors:	Kitley, J, Waters, P, Woodhall, M, Leite, M, Murchison, A, George, J, Kueker, W, Chandratre, S, Vincent, A, Palace, J
Format:	Journal article
Izdano:	2014

Podobne knjige/članki

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
od: Kitley, J, et al.
Izdano: (2014)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
od: Kitley, J, et al.
Izdano: (2014)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
od: Kitley, J, et al.
Izdano: (2012)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
od: Kitley, J, et al.
Izdano: (2011)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
od: Kitley, J, et al.
Izdano: (2012)

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
od: Woodhall, M, et al.
Izdano: (2013)

Prevalence and clinical characteristics of neuromyelitis optica spectrum disorders patients with myelin oligodendrocyte glycoprotein antibodies
od: Sato, D, et al.
Izdano: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
od: Kitley, J, et al.
Izdano: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
od: Kitley, J, et al.
Izdano: (2013)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
od: Waters, P, et al.
Izdano: (2015)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
od: Kitley, J, et al.
Izdano: (2013)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
od: Kitley, J, et al.
Izdano: (2013)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
od: Waters, P, et al.
Izdano: (2016)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
od: Leite, M, et al.
Izdano: (2009)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
od: Nour, M, et al.
Izdano: (2015)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
od: Kitley, J, et al.
Izdano: (2012)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
od: Kim, S, et al.
Izdano: (2013)

Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease.
od: Dos Passos, GR, et al.
Izdano: (2020)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
od: Paul, F, et al.
Izdano: (2007)

Myelin oligodendrocyte glycoprotein antibodies in neurological disease
od: Reindl, M, et al.
Izdano: (2018)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
od: Waters, P, et al.
Izdano: (2008)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
od: Min, J, et al.
Izdano: (2010)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
od: Palace, J, et al.
Izdano: (2010)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
od: Cheng, F, et al.
Izdano: (2014)

Distinction of aquaporin-4 antibody positive neuromyelitis optica from multiple sclerosis using diffusion tensor and myelin water imaging
od: Matthews, L, et al.
Izdano: (2011)

PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
od: Nour, M, et al.
Izdano: (2014)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
od: Wilson, R, et al.
Izdano: (2018)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
od: Jarius, S, et al.
Izdano: (2008)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
od: Nour, M, et al.
Izdano: (2014)

Use of mitoxantrone in neuromyelitis optica.
od: Kitley, J, et al.
Izdano: (2011)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
od: Pittock, S, et al.
Izdano: (2019)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
od: Kitley, J, et al.
Izdano: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
od: Kitley, J, et al.
Izdano: (2012)

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up
od: Waters, P
Izdano: (2019)

Myelin oligodendrocyte glycoprotein CSF testing needs testing
od: Waters, P, et al.
Izdano: (2019)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
od: Kim, S-M, et al.
Izdano: (2016)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
od: Kim, S-M, et al.
Izdano: (2017)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
od: Jarius, S, et al.
Izdano: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
od: Jarius, S, et al.
Izdano: (2008)

Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease
od: Hamid, S, et al.
Izdano: (2017)